Holdings A/S Novo - Insider Trading & Ownership

Entity
Individual
Location
Tuborg Havnevej 19, Hellerup, Denmark
Summary
The estimated net worth of Holdings A/S Novo is at least $477M dollars as of July 26, 2024. Holdings A/S Novo is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $222M. Holdings A/S Novo is the 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $95.8M. Holdings A/S Novo is the 10%+ Owner of Disc Medicine, Inc. and owns shares of Disc Medicine, Inc. (IRON) stock worth about $73.8M. Holdings A/S Novo is the 10%+ Owner of Checkmate Pharmaceuticals, Inc. and owns shares of Checkmate Pharmaceuticals, Inc. stock worth about $22.6M. Holdings A/S Novo is the 10%+ Owner of Reneo Pharmaceuticals, Inc. and owns shares of Reneo Pharmaceuticals, Inc. (RPHM) stock worth about $20.9M. Holdings A/S Novo is the 10%+ Owner of Inogen Inc and owns shares of Inogen Inc (INGN) stock worth about $11.9M. Holdings A/S Novo is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $7.93M. Holdings A/S Novo is the 10%+ Owner of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $5.95M. Holdings A/S Novo is the 10%+ Owner of IO Biotech, Inc. and owns shares of IO Biotech, Inc. (IOBT) stock worth about $5.71M. Holdings A/S Novo is the 10%+ Owner of Metagenomi, Inc. and owns shares of Metagenomi, Inc. (MGX) stock worth about $5.01M. Holdings A/S Novo is the 10%+ Owner of Bolt Biotherapeutics, Inc. and owns shares of Bolt Biotherapeutics, Inc. (BOLT) stock worth about $3.52M. Holdings A/S Novo is the 10%+ Owner of SPRUCE BIOSCIENCES, INC. and owns shares of SPRUCE BIOSCIENCES, INC. (SPRB) stock worth about $1.92M. Holdings A/S Novo is the 10%+ Owner of MINERVA SURGICAL INC and owns shares of MINERVA SURGICAL INC stock worth about $421K.
All Insider Reports
All Insider Reports

Ownership of Holdings A/S Novo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. 10%+ Owner $222M Feb 8, 2022
EWTX Edgewise Therapeutics, Inc. 10%+ Owner $95.8M Sep 14, 2022
IRON Disc Medicine, Inc. 10%+ Owner $73.8M Jun 28, 2023
CMPI Checkmate Pharmaceuticals, Inc. 10%+ Owner $22.6M Feb 23, 2022
RPHM Reneo Pharmaceuticals, Inc. 10%+ Owner $20.9M Jun 23, 2023
INGN Inogen Inc 10%+ Owner $11.9M Jun 2, 2021
VERV Verve Therapeutics, Inc. 10%+ Owner $7.93M Jun 21, 2021
CYT Cyteir Therapeutics, Inc. 10%+ Owner $5.95M Jul 19, 2023
IOBT IO Biotech, Inc. 10%+ Owner $5.71M -$1.89M -24.9% Jul 25, 2024
MGX Metagenomi, Inc. 10%+ Owner $5.01M Feb 9, 2024
BOLT Bolt Biotherapeutics, Inc. 10%+ Owner $3.52M Jul 13, 2022
SPRB SPRUCE BIOSCIENCES, INC. 10%+ Owner $1.92M -$2.05M -51.6% Mar 21, 2024
UTRS MINERVA SURGICAL INC 10%+ Owner $421K Oct 26, 2021

Insider Transactions Reported by Holdings A/S Novo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.